NCT00003907 2023-07-05
Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
Eastern Cooperative Oncology Group
Phase 2 Completed
Clinical Trials
9 trialsNCT00956930 2022-11-21
Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery
Northwestern University
Phase 2 Completed
NCT01011010 2018-01-05
Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT00047229 2017-11-08
Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
University Health Network, Toronto
Phase 2 Completed
NCT00108953 2014-10-31
A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma
Bayer
Phase 2 Completed
NCT00003912 2013-12-04
Chemotherapy in Treating Children With Liver Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00012324 2013-06-26
Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT01042041 2013-02-26
Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00004248 2011-03-07
Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Roswell Park Cancer Institute
Phase 2 Completed